Identifying genetic risk variants for coronary heart disease in familial hypercholesterolemia: an extreme genetics approach.
Cast your vote
You can rate an item by clicking the amount of stars they wish to award to this item.
When enough users have cast their vote on this item, the average rating will also be shown.
Your vote was cast
Thank you for your feedback
Thank you for your feedback
Oosterveer, Daniëlla M
Aulchenko, Yurii S
Uitterlinden, André G
Defesche, Joep C
van Duijn, Cornelia M
Karlsson, Hróbjartur D
van Vark-van der Zee, Leonie
Blommesteijn-Touw, Adriana C
Liem, Anho H
van der Ouderaa, Frans J
de Leeuw, Peter W
Simoons, Maarten L
Schinkel, Arend Fl
Green, Martin R
Zwinderman, Aeilko H
Johnson, Keith J
Witteman, Jacqueline Cm
Humphries, Steve E
Kastelein, John Jp
Sijbrands, Eric Jg
MetadataShow full item record
CitationEur. J. Hum. Genet. 2015, 23 (3):381-7
AbstractMutations in the low-density lipoprotein receptor (LDLR) gene cause familial hypercholesterolemia (FH), a disorder characterized by coronary heart disease (CHD) at young age. We aimed to apply an extreme sampling method to enhance the statistical power to identify novel genetic risk variants for CHD in individuals with FH. We selected cases and controls with an extreme contrast in CHD risk from 17 000 FH patients from the Netherlands, whose functional LDLR mutation was unequivocally established. The genome-wide association (GWA) study was performed on 249 very young FH cases with CHD and 217 old FH controls without CHD (above 65 years for males and 70 years of age for females) using the Illumina HumanHap550K chip. In the next stage, two independent samples (one from the Netherlands and one from Italy, Norway, Spain, and the United Kingdom) of FH patients were used as replication samples. In the initial GWA analysis, we identified 29 independent single nucleotide polymorphisms (SNPs) with suggestive associations with premature CHD (P<1 × 10(-4)). We examined the association of these SNPs with CHD risk in the replication samples. After Bonferroni correction, none of the SNPs either replicated or reached genome-wide significance after combining the discovery and replication samples. Therefore, we conclude that the genetics of CHD risk in FH is complex and even applying an 'extreme genetics' approach we did not identify new genetic risk variants. Most likely, this method is not as effective in leveraging effect size as anticipated, and may, therefore, not lead to significant gains in statistical power.
DescriptionTo access publisher's full text version of this article click on the hyperlink at the bottom of the page
RightsArchived with thanks to European journal of human genetics : EJHG
- Familial hypercholesterolemia in the Finnish north Karelia. A molecular, clinical, and genealogical study.
- Authors: Vuorio AF, Turtola H, Piilahti KM, Repo P, Kanninen T, Kontula K
- Issue date: 1997 Nov
- Premature coronary heart disease and autosomal dominant hypercholesterolemia: Increased risk in women with LDLR mutations.
- Authors: Ahmad Z, Li X, Wosik J, Mani P, Petr J, McLeod G, Murad S, Song L, Adams-Huet B, Garg A
- Issue date: 2016 Jan-Feb
- Next generation sequencing to identify novel genetic variants causative of autosomal dominant familial hypercholesterolemia associated with increased risk of coronary heart disease.
- Authors: Al-Allaf FA, Athar M, Abduljaleel Z, Taher MM, Khan W, Ba-Hammam FA, Abalkhail H, Alashwal A
- Issue date: 2015 Jul 1
- The molecular genetic basis and diagnosis of familial hypercholesterolemia in Denmark.
- Authors: Jensen HK
- Issue date: 2002 Nov
- Impact of low-density lipoprotein receptor mutational class on carotid atherosclerosis in patients with familial hypercholesterolemia.
- Authors: Junyent M, Gilabert R, Jarauta E, Núñez I, Cofán M, Civeira F, Pocoví M, Mallén M, Zambón D, Almagro F, Vega J, Tejedor D, Ros E
- Issue date: 2010 Feb